What is the experience of our patients with transient hypoparathyroidism after total thyroidectomy?
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32654859.
- Also identified by DOI 10.1016/j.surg.2020.04.029 and PMC identifier 8641920.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We sought to better understand the experience of patients with transient hypoparathyroidism using patient interviews and quality of life surveys. This is a prospective analysis of 62 patients after total thyroidectomy at a high-volume institution. Semistructured patient interviews and quality of life surveys were conducted preoperatively and postoperatively at 2 weeks, 6 weeks, 6 months, and 1 year and compared based on postoperative parathyroid hormone levels. Postoperative parathyroid hormone levels were <10 pg/mL in 32% of patients (n = 20), 10 to 20 pg/mL in 19% (n = 12), and >20 pg/mL in 48% (n = 30). Hypocalcemic symptoms at 2 weeks were reported in 28 of 55 patients (51%), but patients felt "well prepared" and reported it "wasn't a big deal." If symptoms persisted at 6 weeks, they became more bothersome. At 6 months and 1 year, patients reported calcium supplementation prevented most symptoms and did not interfere with daily activities. Quality of life as measured by the European Organization for Research and Treatment of Cancer and the 12-Item Short Form Survey demonstrated a slight improvement at 1 year postoperatively regardless of parathyroid hormone level. Early postoperative transient hypoparathyroidism is common but when appropriately managed did not have a substantial negative impact on the overall quality of life.
Medical subject headings
- Hypocalcemia
- Hypoparathyroidism
- Postoperative Complications
- Quality of Life
- Thyroid Neoplasms
- Thyroidectomy